Physician profile
Tamara Lopez
NPI 1417669409
$974.11
in general payments reported to CMS, 2019-2025
13 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.70 · 2024: $537 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.12 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $327.96 | 2023-2025 | Erleada, Rybrevant, Akeega |
| Merck Sharp & Dohme LLC | $174.97 | 2024-2025 | Keytruda, Welireg |
| Pfizer INC. | $146.96 | 2024-2025 | |
| Seagen INC. | $74.99 | 2024 | |
| Eisai INC. | $60.74 | 2024-2025 | |
| Daiichi Sankyo INC. | $27.15 | 2024 | Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $26.66 | 2025 | Alunbrig |
| Tersera Therapeutics LLC | $25.37 | 2025 | Zoladex |
| Incyte Corporation | $24.91 | 2025 | Niktimvo |
| Novartis Pharmaceuticals Corporation | $23.01 | 2024 | |
| Jazz Pharmaceuticals INC. | $21.60 | 2025 | |
| Tempus Ai, INC | $19.99 | 2024 | Xt Cdx |
| Caris Mpi, INC. | $19.80 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.